UTHealth Research

September 14, 2023

American Heart Association’s ASA adopts Spanish-language R.A.P.I.D.O. acronym for stroke awareness created by Cizik School of Nursing at UTHealth Houston

Written By: Deborah Mann Lake | Updated: September 14, 2023

R.Á.P.I.D.O., a culturally relevant acronym created under the leadership of Jennifer Beauchamp, PhD, RN, at Cizik School of Nursing at UTHealth Houston to raise awareness of stroke signs in the Spanish-speaking Hispanic/Latino community and save lives, has been adopted by the American Stroke Association (ASA), the organization announced today.

September 12, 2023

UTHealth Houston researcher to present abstract detailing new mouse model for brain arteriovenous malformations at NIH meeting

Written By: Caitie Barkley | Updated: September 12, 2023

An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.

September 12, 2023

$3.3 million grant awarded to UTHealth Houston to develop diagnostic test for rapidly increasing congenital syphilis

Written By: Jeannette Sanchez | Updated: September 12, 2023

A five-year, $3.3 million grant to develop a molecular diagnostic test for congenital syphilis has been awarded to researchers from UTHealth Houston by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.

August 16, 2023

Several vaccines associated with reduced risk of Alzheimer’s disease in adults 65 and older

Written By: Caitie Barkley | Updated: August 16, 2023

Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer’s disease, according to new research from UTHealth Houston.

August 11, 2023

UTHealth Houston joins SATURN trial, studying role of statins in recurrent intracerebral hemorrhage

Written By: Caitie Barkley | Updated: August 11, 2023

A clinical trial evaluating the role of statins in the risk of recurrent intracerebral hemorrhage (ICH) in patients presenting with ICH, has opened for enrollment at UTHealth Houston.

August 8, 2023

UTHealth Houston researcher awarded $3.1M NIH grant to study sudden unexpected death in epilepsy

Written By: Caitie Barkley | Updated: August 8, 2023

A five-year, $3.1 million grant to study preventive strategies for sudden unexpected death in epilepsy (SUDEP) has been awarded to UTHealth Houston by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke.

August 3, 2023

UTHealth Houston set to enroll patients for two long COVID clinical trials through NIH

Written By: Halle Jones | Updated: August 3, 2023

Two clinical trials that will evaluate drugs, biologics, medical devices, and other therapies for long COVID that are sponsored by the National Institutes of Health (NIH) will launch at UTHealth Houston.

July 24, 2023

UTHealth Houston study on seasonality of teen suicidality in JAMA Network Open

Written By: Halle Jones | Updated: July 24, 2023

The incidences of teen suicidality including self-harm, suicidal ideation, and suicide attempts increased nationally between 2016 and 2021; were at seasonal high peaks in April and October; and were at their lowest when schools were shut down during the COVID-19 pandemic, according to research at UTHealth Houston.

July 18, 2023

Women less likely to be routed to comprehensive stroke centers for large vessel acute ischemic stroke, according to UTHealth Houston research

Written By: Caitie Barkley | Updated: July 18, 2023

Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centers, women with large vessel occlusion acute ischemic stroke are less likely to be routed to the centers compared to men, according to a new study from UTHealth Houston.

July 7, 2023

Researchers uncover how a genetic mutation can cause individuals with normal cholesterol levels to develop coronary artery disease at a young age

Written By: Jeannette Sanchez | Updated: July 7, 2023

A novel molecular pathway to explain how a mutation in the gene ACTA2 can cause individuals in their 30s – with normal cholesterol levels and no other risk factors — to develop coronary artery disease has been identified, according to researchers with UTHealth Houston.

Find a Doctor

Select an area

Patient Care

Patient Resources

New Patient?

Billing

Patient Services

1-855-877-2808

Customer Service Hours

Mon – Thu, 8 a.m. to 8 p.m.

Fri, 8 a.m. to 5 p.m.

Sat, 9 a.m. to 1 p.m.

CST time zone

Insurance

COVID-19

More

News & Articles

September 14, 2023

Written By: Deborah Mann Lake | Updated: September 14, 2023

September 12, 2023

Written By: Caitie Barkley | Updated: September 12, 2023

September 12, 2023

Written By: Jeannette Sanchez | Updated: September 12, 2023

August 16, 2023

Written By: Caitie Barkley | Updated: August 16, 2023

August 11, 2023

Written By: Caitie Barkley | Updated: August 11, 2023

August 8, 2023

Written By: Caitie Barkley | Updated: August 8, 2023

August 3, 2023

Written By: Halle Jones | Updated: August 3, 2023

July 24, 2023

Written By: Halle Jones | Updated: July 24, 2023

July 18, 2023

Written By: Caitie Barkley | Updated: July 18, 2023

July 7, 2023

Written By: Jeannette Sanchez | Updated: July 7, 2023

Categories

Categories

UTHealth Houston Professional Building

6410 Fannin StreetHouston, Texas 77030

QUICK LINKS

© Copyright 2023 – The University of Texas Health Science Center at Houston (UTHealth Houston)

Contact / Feedback | Report Error | Patient Privacy | Web File Viewing | Site Policies | Employee Links

Find a Doctor

Find Locations

Patient Care

Patient Info

Why UT Physicians

6410 Fannin Street
Houston, Texas 77030